Latest filing published 28 Mar 2022 for Marker Therapeutics, Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Anthony H. Kim: trading record in brief
Anthony H. Kim is a declared insider of Marker Therapeutics, Inc. (finance chief), with filings sourced from SEC (Form 4). In total, 2 filings cover trades dated 24 March 2022.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 28 March 2022, the filings show a share grant worth €16k in Marker Therapeutics, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Anthony H. Kim
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 150,512 shares0Common StockSEC:0001209191-22-021394:0
1 of 1 declaration
